2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds

Hiroyuki Kai, Yasuhide Morioka, Takami Murashi, Koichi Morita, Satomi Shinonome, Hitoshi Nakazato, Keiko Kawamoto, Kohji Hanasaki, Fumiyo Takahashi, Shin ichi Mihara, Tohko Arai, Kohji Abe, Hiroshi Okabe, Takahiko Baba, Takayoshi Yoshikawa, Hideyuki Takenaka

研究成果査読

30 被引用数 (Scopus)

抄録

2-Arylimino-5,6-dihydro-4H-1,3-thiazines have been identified as a novel class of cannabinoid agonists. A lead structure with moderate activity was discovered through a high throughput screening assay. Structure-activity relationships led to the discovery of potent agonists of CB2 receptor. The most potent compound 13 displays Ki values of >5000 and 9 nM to CB1 and CB2 receptors, respectively.

本文言語English
ページ(範囲)4030-4034
ページ数5
ジャーナルBioorganic and Medicinal Chemistry Letters
17
14
DOI
出版ステータスPublished - 7月 15 2007
外部発表はい

ASJC Scopus subject areas

  • 生化学
  • 分子医療
  • 分子生物学
  • 薬科学
  • 創薬
  • 臨床生化学
  • 有機化学

フィンガープリント

「2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル